A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.
about
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An updateGuide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitisGoat Milk Yoghurt by Using Lacto-B Culture Modulates the Production of Tumor Necrosis Factor-Alpha and Interleukin-10 in Malnourished Rats.Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains.Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilliRole of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.Gut microbiota, probiotics and inflammatory bowel disease.Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections.The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/inflammatory diseases.Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in MiceOuter Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells.The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine.Wild-type and IL10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifidobacterium animalis subspecies lactis and inulin.Clinical review: Probiotics in critical care.Lactobacillus rhamnosus L34 Attenuates Gut Translocation-Induced Bacterial Sepsis in Murine Models of Leaky Gut.E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy.A gut feeling about immunity.Preventive effects of Escherichia coli strain Nissle 1917 with different courses and different doses on intestinal inflammation in murine model of colitis.Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917: a controlled pilot trial.Does Modification of the Large Intestinal Microbiome Contribute to the Anti-Inflammatory Activity of Fermentable Fiber?
P2860
Q26746916-FA23F20B-9F78-47D7-9D92-B1F2E89EC8D0Q34165056-EA285827-1951-4525-B9C0-2D4175C4221AQ34579758-BED25F51-E867-4ECF-84BB-328FCA5D343CQ35859785-8529BCFB-6EA0-432F-BAAD-D5EB12D78970Q35892618-DA9A1C62-E679-4783-AE0C-3555992023FBQ36361827-44A21AB7-2CCC-4FA7-9F25-D9074763D341Q36599131-4DCE54B5-D692-4F82-B811-64FF8BCFDE56Q36890709-B96486E9-4F63-4FE2-904C-26AFD98B668FQ37299999-C0F6869C-63B1-4CE9-B58D-BD80A29AC267Q37713374-5F8DD2F9-5B4B-4123-B71E-079AC2577A79Q37858913-81EA3078-16D7-4EEE-BB6A-C05E25771987Q37969596-88818F38-38A0-4632-95B0-E66FB8B0BC81Q39233059-8203FE9A-666D-47EE-95C0-4C9A77A945CFQ39283731-46FB2F72-6BAB-4131-92EA-A307746B113CQ40072834-9F6B8546-F9CA-4912-BC23-1C1D9A31A14FQ40974571-9033DE4C-7CB5-4120-BCD8-2BB971F73F67Q42352756-C091808D-F724-48B1-A13B-F7C73D817AB1Q44587821-FAE9D8CA-448A-41BB-8760-98DD87B63B7BQ44899033-5F561251-7E71-49B7-AFC4-540EB5CE469DQ46626203-82D765E4-58B2-4A1C-B899-6B39B0140CF7Q47644238-6B044A01-1C8D-428D-9A0B-D4451031CADAQ52647653-7ED05DFD-6115-474E-B78D-9A8CCBF8FDB8Q53195657-C5243FB4-5018-40A6-86E4-3EFBF836BE4CQ54283890-B41A9F18-4C93-4125-9286-45D3D814FDBDQ55350606-4D17DAB3-FC7A-4667-A494-D157862FE7B9Q58133618-3AE845BC-6F7F-4BEA-B75F-4944FE96AB29
P2860
A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A probiotic strain of Escheric ...... haride-induced sepsis in mice.
@en
A probiotic strain of Escheric ...... haride-induced sepsis in mice.
@nl
type
label
A probiotic strain of Escheric ...... haride-induced sepsis in mice.
@en
A probiotic strain of Escheric ...... haride-induced sepsis in mice.
@nl
prefLabel
A probiotic strain of Escheric ...... haride-induced sepsis in mice.
@en
A probiotic strain of Escheric ...... haride-induced sepsis in mice.
@nl
P2093
P2860
P921
P1476
A probiotic strain of Escheric ...... charide-induced sepsis in mice
@en
P2093
A Zarzuelo
D Camuesco
M Comalada
P2860
P304
P356
10.1111/J.1476-5381.2009.00270.X
P407
P577
2009-05-26T00:00:00Z